To provide BIO-medical and behavioral research resources and clinical research coordinating services to support the nida clinical trials network (CTN) heal studies.
Ended Awarded Last action
- Contract number
- 75N95023F00001
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,951,204
Award facts
- Contract value 100% obligated
- $4,951,204.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $842,918 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Original award | $4,108,286 |
About this award
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to The Emmes Company LLC, a for-profit limited liability company. The $4,951,204.00 award is for a Delivery Order task under NIDA's Clinical Trials Network (CTN) Clinical Coordinating Center, a larger Indefinite Delivery contract vehicle. The contract is for the provision of biomedical and behavioral research resources as well as clinical research coordinating services to support NIDA's HEAL (Helping to End Addiction Long-term) studies. This cost-plus-fixed-fee contract has a completion date of February 23, 2024. The Emmes Company, which has extensive experience providing data management, statistical analysis, and clinical trial support services to NIH institutes, will fulfill the contract requirements from its facility in Potomac, Maryland. No set-aside designation was used for this award.
Quick answers
Who was awarded contract 75N95023F00001?
75N95023F00001 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on February 24, 2023.
How much is contract 75N95023F00001 worth?
The government has obligated $4,951,204 on 75N95023F00001.
Is contract 75N95023F00001 an order under another contract?
Yes. 75N95023F00001 is a delivery order under 75N95020D00012, an indefinite delivery contract.
Was contract 75N95023F00001 competed?
The extent of competition for 75N95023F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award